ContraFect

ContraFect Financial Leverage

The Financial Leverage (Equity Multiplier) of ContraFect (CFRXQ) as of Oct 19, 2026 is -1.75. In the previous year, Financial Leverage (Equity Multiplier) was 1.35 — a change of -229.08% (lower).

Financial Leverage

-1.75

YoY

-229.08%

Last updated:

Financial Leverage (Equity Multiplier) of ContraFect is 2022 -1.75 . Financial Leverage (Equity Multiplier) of ContraFect was 2021 1.35 . It decreases by -229.08% lower compared to the previous year.

The ContraFect Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2015
1.17 USD
Jan 1, 2016
1.93 USD
Jan 1, 2017
1.61 USD
Jan 1, 2018
5.93 USD
Jan 1, 2019
2.25 USD
Jan 1, 2020
4.05 USD
Jan 1, 2021
1.35 USD
Jan 1, 2022
-1.75 USD
The ContraFect Financial Leverage history
YEARFinancial LeverageYoY
-1.75-229.08%
1.35-66.62%
4.05+79.80%
2.25-62.03%
5.93+268.71%
1.61-16.55%
1.93+64.97%
1.17-0.50%
1.17—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ContraFect Stock analysis

What does ContraFect do? ContraFect Corp, based in Yonkers, New York, is a clinical-stage biotechnology company focused on developing direct lytic agents (DLAs) such as lysins and amurin peptides to treat life-threatening antibiotic-resistant infections. The company, listed in 2014, employs 23 people and is advancing its lead candidate exebacase (CF-301) for MRSA bloodstream infections and chronic prosthetic joint infections, alongside CF-370 targeting gram-negative bacteria. ContraFect is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ContraFect stock

Financial Leverage (Equity Multiplier) of ContraFect is -1.75 in 2022.

Financial Leverage (Equity Multiplier) of ContraFect changed from 1.35 to -1.75, representing a -229.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) ContraFect since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s ContraFect with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — ContraFect

All Key Metrics — ContraFect